Crohn's fistula study reveals long-term recurrence risks after standard treatment
NCT ID NCT06514092
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study looked at 63 Crohn's disease patients who had anal fistulas treated with anti-TNF drugs and seton drainage. The goal was to see how often fistulas came back over the long term and what factors might increase the risk of recurrence. The findings could help doctors improve treatment plans to prevent fistulas from returning.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Toulouse
Toulouse, France
Conditions
Explore the condition pages connected to this study.